MedPath

Study held to see the effect of Ajmodadi Vati on Prameha with special reference to Diabetis Mellitus Type 2.

Phase 2
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2023/04/051266
Lead Sponsor
Bhagwan Kakasaheb Muley
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient with fasting blood sugar >126mg/dl upto 200mg/dl and post prandial blood sugar >200mg/dl upto 450mg/dl

Exclusion Criteria

Diabetes mellitus type 2 Acromegaly cushings syndrome and pancreatic disorders

Pregnant and lactating mothers

Patients with known case of Diabetic nephropathy and retinopathy

Patients with gastrointestinal disease liver disease and tumors cardiovascular disease acute myocardial infarction DKA hyperosmolar non ketotic diabetic coma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the add on effect of Ajmodadi vati in the management of prameha.Timepoint: 30 days study, follow up on 15th and 30th day.
Secondary Outcome Measures
NameTimeMethod
To evaluate the effectivness of Ajmodadi vati on signs and <br/ ><br>symptoms of Prameha. <br/ ><br>Timepoint: 30 days study, follow up on 15th and 30th day.
© Copyright 2025. All Rights Reserved by MedPath